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The aqueous and methanol extracts from the dry bulbils of Dioscorea bulbifera L. var sativa (Dioscoreaceae)—evaluated orally
at the doses of 300 and 600mg/kg against pain induced by acetic acid, formalin, pressure and against inﬂammation induced by
carrageenan, histamine, serotonin and formalin in mice and rats, showed a dose dependant inhibition of pain and inﬂammation
with a maximum eﬀect of 56.38%, 73.06% and 42.79% produced by the aqueous extract, respectively on pain induced by acetic
acid, formalin and pressure while the methanol extract at the same dose respectively inhibited these models of pain by 62.70%,
84.54% and 47.70%. The oral administration of aqueous and methanol extracts caused signiﬁcant anti-inﬂammatory activity on
paw oedema induced by histamine, serotonin and formalin. The present results show that the bulbils of Dioscorea bulbifera var
sativa possess potent analgesic and anti-inﬂammatory activities. These activities may results from the inhibition of inﬂammatory
mediators such as histamine, serotonin and prostaglandins. Thus, the analgesic activity of the bulbils of Dioscorea bulbifera may be
at least partially linked to its anti-inﬂammatory activity.
1.Introduction
Dioscoreaceae are distributed throughout the tropics and
constitute a family consisting mainly of tropical climbers.
Almost all species are perennial herbaceous or shrubby
climbers with well-developed tubers or rhizomes. Leaves are
usually alternate, simple, but sometimes palmately lobed
or compound [1]. Dioscorea is a genus in the mono-
cotyledonous family Dioscoreaceae [2]. Dioscorea bulbifera
L. is a glabrous nonspiny climber of 10–20 feet high
with bulbils 1–8cm in size [3]. Tubers are toxic or edible
accordingtothevariety;theyarerenewedannually.Dioscorea
bulbifera L. var sativa commonly called “letoucfong” in
the Bamboutos division (West Province of Cameroon)
grows wild and has bitter tubers and bulbils [4]. A
steroidal saponin, spiroconazole A, a phenanthrene, 2,7-
dihydroxy-4-methoxyphenanthrene, ﬂavonoids as quercetin,
quercetin-3-O-β-D-glucopyranoside, and quercetin-3-O-β-
D-galactopyranoside, and seven clerodane diterpenoids
namely, bafoudiosbulbins A, B, C, D, E, F, and G have been
isolated from the methanol extract of the bulb of Dioscorea
bulbifera var sativa [5–8]. Dioscorea bulbifera L. var sativa is
used in Bangladesh for the treatment of leprosy and tumours
[4] and by the native people of the western highlands of
Cameroon for the treatment of pig Cysticercosis, though
the tubers, after collection during the farming period, are
totally destroyed and burnt because of their high bitterness.
The roots of Dioscorea bulbifera L., although considered
poisonous because of cytotoxic activity, have been used in
Chinese medicine as a remedy for sore throat and for struma
[9]. In Zimbabwe, this plant is used as an infusion to apply
on cuts and sores, both for humans and animals while in
Cameroon and Madagascar, the pounded bulbs are applied
to abscesses, boils, and wound infections [10]. Its bulbs
are used in India to treat piles, dysentery, syphilis and are
applied to ulcers, pain, and inﬂammation [11]. Although
the plant material has been long used to treat pain and
inﬂammation, no scientiﬁc work has been carried out to
ascertain the claimed properties. The present work was then
undertaken to evaluate the analgesic and anti-inﬂammatory2 Evidence-Based Complementary and Alternative Medicine
eﬀects of the aqueous and methanol extracts from the bulbils
of Dioscorea bulbifera in mice and rats.
2.MaterialsandMethods
2.1. Plant Material. The bulbils of Dioscorea bulbifera L.
var sativa were collected in Bafou village near Dschang
(West province of Cameroon) in February 2007. The plant
was identiﬁed by Dr G. Achoundong, Cameroon National
Herbarium, Yaound´ e, where a voucher specimen (Ref:
22211/SRF/CAM) was deposited.
The aqueous extract of the bulbils of Dioscorea bulbifera
was obtained by maceration of 5kg of the dried and
pulverized bulbils in distilled water for 3 days. The ﬁltrate
was evaporated at 40◦C to produce 156g of a solid residue,
corresponding to a yield of 3.12%.
The dried and pulverized bulbils of Dioscorea bulbifera
(12kg) were extracted two times (each time for 24 hours)
with MeOH-H2O (8:2). The ﬁltrate obtained was concen-
tratedunderreducedpressuretoyield530gofadarkresidue,
representing the methanol extract (4.42% yield).
For the phytochemical screening, the test of Shinoda was
used to reveal the presence of ﬂavonoids [12], Ehrich’s test
for furanoids [13], while saponins were revealed as described
by Hostettmann et al. [14].
2.2. Animals. White adult mice Mus musculus (weighing 25–
30g) and adult Wistar rats (weighing 180–200g), of either
sex, obtained from the animal house of the Laboratory
of Animal Physiology and Phytopharmacology of the Uni-
versity of Dschang (Cameroon) were used in the present
study. These animals were raised under natural conditions
(temperature: 21 ±2◦C; 12h/12h light-dark cycle) and were
allowed free access to water and food. Experiments were
carried out on groups of 6 animals each. All experimental
proceduresusedinthepresentstudyfollowedthe“Principles
of Laboratory Animal Care” from NIH publication Nos.
85-23 and were approved by the ethic committee of the
Cameroon Ministry of Scientiﬁc Research and Technology
which has adopted the guidelines established by the Euro-
pean Union on Animal Care and Experimentation (CEE
Council 86/609).
2.3. Chemicals. Acetic acid, formaldehyde, pyrilamine
maleate, carrageenan, histamine, serotonin, DMSO, and
tween 80 were obtained from Sigma Chemical Co. (St.Louis,
MO, USA), while indomethacin (Indocid, Merck Sharp-
Dolme Chibret, Fr.), aspirin (UPSA), and diclofenac
(Olfen-100 SR) were obtained from a local pharmacy. All
these chemicals and the aqueous extract were prepared
in normal saline (0.9%) except indomethacin that was
dissolved in 3% DMSO. The methanol extract was prepared
in a mixture of 2.5% DMSO and 2.5% tween 80.
2.4. Analgesic Activity
2.4.1. Animal Allotment and Treatment. In each analgesic
test, seven groups of animals were used. Groups 1 and
2 served as negative controls and were treated with dis-
tilled water and mixture of Tween (2.5%)/DMSO (2.5%),
respectively. Group 3 was used as positive control and
received indomethacin (10mg/kg). The 4 remaining groups
were treated with the aqueous or methanol extract of
the bulbils of Dioscorea bulbifera at the doses of 300
and 600mg/kg. All the treatments were administered
orally.
2.4.2. Acetic Acid-Induced Abdominal Writhing Test. This test
was performed as previously described by H. G. Vogel and
W. H. Vogel [15]. One hour after administration of the
treatments, acetic acid solution (0.6%; v/v) was injected
intraperitoneally (0.1mL/10g) to each animal. The number
of writhing produced in these animals was counted for 30
min,starting5minafteracidinjection.Thepercentageofthe
analgesic activity was calculated as follows:
Inhibition(%) =
Nc−Nt
Nc
×100, (1)
where Nc = mean number of writhing in control group; Nt
= mean number of writhing in treated group.
2.4.3. Formalin Test. The formalin-induced paw licking was
studied in mice using the method described by Nguelefack et
al. [16]. In this method, 20μL of 2.5% formalin was injected
into the subcutaneous tissue of the plantar surface of the left
hind paw of rats 1 hour after administration of drugs. The
time the animal spent licking the injected paw was counted
in two diﬀerent phases: from 0–5min postinjection (early
phase) and from 15–30min postinjection (late phase). The
percentage of analgesic activity at each phase was calculated
using the following formula:
Inhibition(%) =
C −T
C
×100, (2)
with C = mean time in control group for each phase and T =
mean time in treated group for each phase.
2.4.4. Analgesy Meter Test. This experiment was conducted
as previously described by Kamanyi et al. [17]. The rat was
suspended vertically while its left hind paw placed between
the plinth and the ﬁnger of the Ugo Basile analgesy meter.
This instrument generates a linearly increasing mechanical
force or pressure by dome-shaped on the dorsal surface on
the rat’s hind paw. As the applied pressure increases, it gets
to a point where the animal struggles to free its paw. This
point was taken as the threshold level at which the animal
feels pain. This threshold point was determined before, 0.5,
1, 2, and 4 h after treatment. Protection rates were calculated
as follows:
Protection(%) =
(Pt −Po)test −(Pt − Po)control
(Pt −Po)control
×100,
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withPo=thresholdvaluebeforeadministrationofdrugsand
Pt = threshold value at time t after administration of drugs.
2.5. Anti-Inﬂammatory Activity
2.5.1. Carrageenan-Induced Paw Oedema. The experiment
was carried out as described by Winter et al. [18]. Adult
rats were divided and treated as described in the analgesic
section. The paw volume of the rats was measured plesthys-
mographically (UGO BASILE-7140) before treatments (V0).
One hour after treatment, 0.1mL of carrageenan (1% in
0.9% NaCl) was administered into the subcutaneous tissue
of the plantar surface of the right hind paw. Then the
v o l u m eo fp a ww a st a k e na t0 . 5 ,1 ,2 ,3 ,4 ,5 ,a n d6h o u r s
after carrageenan administration (Vt). The oedema was
expressed as an increase in the volume of paw (ΔV), and
the percentage of inhibition (I%) for each treatment was
obtained as follows: ΔV = Vt−V0
I(%) =
ΔVc−ΔV tr
ΔVc
×100, (4)
where ΔV tr = right hind paw average increased volume in
treated group and ΔVc= right hind paw average increase in
control groups.
2.5.2. Paw Oedema Induced by Histamine and Serotonin.
Animals were divided as in the previous experiment but
the control group received pyrilamine maleate at 1mg/kg.
Oedema was induced by subcutaneous injection of 0.1mL
of freshly prepared solutions of serotonin (10mg/mL) or
histamine (1mg/mL) into the hind paws of the rats 1 hour
afteroraladministrationofdrugs.Thevolumeoftheinjected
paws was measured 30min and 1 hour after injection of
serotonin or histamine, respectively [19]. The percentage
inhibition induced by each drug was calculated as in the
carrageenan test.
2.5.3. Formalin-Induced Paw Oedema. This experiment was
undertaken using the methodology previously described by
Dimo et al. [20]. Seven groups of rats were used: two
negative controls treated with distilled water or with the
mixture Tween (2.5%)/DMSO (2.5%), one positive control
treated with diclofenac (10mg/kg), and 4 groups receiving
the aqueous or the methanol extract at the doses of 300
and 600mg/kg. Thirty minutes later, 0.1mL formalin (2%
in 0.9% NaCl) was injected into the subplanter area of right
hind paw of rats. The paw volume was determined acutely by
the plethysmographic method before drugs’ administration
and 1, 2, and 4 hours following the injection of formalin.
The same animals were used for the chronic test. They were
treated daily after the measurement of the paw volume for 10
consecutive days. A second injection of formalin was given
on the third day.
2.6. Statistical Analysis. Results are presented as mean ±
Standard Error of the Mean (SEM). One-way ANOVA
followedbytheTukeyposttestortwo-waysANOVAfollowed
by Bonferroni post test were used where necessary for
statistical analysis.
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Figure 1: Eﬀects of aqueous and methanol extracts of the bulbils
of Dioscorea bulbifera L. var sativa on acetic acid-induced pain in
mice. Each bar represents the mean ± SEM of 6 animals; cP<. 001
statistically signiﬁcant compared to their respective control.
3. Results
3.1. Phytochemical Studies. Phytochemical screening of
aqueous and methanol extracts revealed the presence of
ﬂavonoids, furanoids, and saponins.
3.2. Acetic Acid-Induced Writhing Test. The oral administra-
tion of the aqueous and methanol extracts of the bulbils
of Dioscorea bulbifera in mice signiﬁcantly (P<. 001)
reduced in a dose-dependent manner the number of mouse
abdominalconstrictionsinducedbyaceticacid.Theaqueous
extract at doses of 300 and 600mg/kg showed a protective
eﬀect of 47.02% and 56.38%, respectively. At the same
doses, the methanol extract induced a protective eﬀect of
51.89% and 62.70%, respectively. The methanol extract
at 600mg/kg exhibited the same activity as indomethacin
(62.75%) (Figure 1).
3.3. Formalin Test. The intraplantar injection of 20μLo f
formalin (2.5%) into the right hind paw generated a
classical biphasic nociceptive response. As shown in Figure 2,
plant extracts (300 and 600mg/kg) signiﬁcantly and dose-
dependently reduced the nociception in both the early and
late phases. The aqueous and methanol extract signiﬁcantly
reduced the licking time at the ﬁrst phase of observa-
tion by 44.80% and 57.78% at 600mg/kg, respectively.
Indomethacin did not show signiﬁcant activity on this
ﬁrst phase. During the second phase of observation, the
aqueous and methanol extracts at the dose of 600mg/kg
showed a maximum protective eﬀect of 73.06% and 84.54%,
respectively while indomethacin signiﬁcantly inhibited it by
42.22%.
3.4. Analgesy Meter Test. The aqueous extract at the doses
300and600mg/kgsigniﬁcantly(P<. 01)reducedtheanimal4 Evidence-Based Complementary and Alternative Medicine
0
15
30
45
60
75
90
L
i
c
k
i
n
g
t
i
m
e
(
s
)
Control Indomethacin
10mg/kg
EA
300mg/kg
EA
600mg/kg
Treatment
First phase
Second phase
c
c
c
c
(a)
0
15
30
45
60
75
90
105
L
i
c
k
i
n
g
t
i
m
e
(
s
)
Control Indomethacin
10mg/kg
EM
300mg/kg
EM
600mg/kg
Treatment
First phase
Second phase
c
c
c c
c
(b)
Figure 2: Eﬀects of aqueous (EA) (a) and methanol (EM) (b)
extracts of the bulbils of Dioscorea bulbifera L. var sativa on
formalin-induced pain in mice. Each bar represents the mean ±
SEM of 6 animals; cP<. 001 statistically signiﬁcant compared to
their respective control.
sensitivity to pain induced by pressure, raising the thresh-
old of reaction by 29.04% and 42.79%, respectively. The
methanol extract induced an inhibition of 47.70% at the
dose of 600mg/kg while indomethacin did not show any
signiﬁcant eﬀect (Figure 3).
3.5. Carrageenan-Induced Paw Oedema. As it can be seen
from Figure 4, the subplantar injection of the carrageenan
produced an inﬂammatory oedema which increased gradu-
ally, reaching its maximum at the 4th hour after injection.
The aqueous extract at the dose 600mg/kg exhibited an
anti-inﬂammatory activity that became signiﬁcant 2 hours
after the injection of carrageenan and was maintained all
along the experiment with a maximum of 60.63%. The
methanol extract (300 and 600mg/kg) induced signiﬁcant
(P<. 001) anti-inﬂammatory eﬀect that increased progres-
sively and reached a maximum (80%) at the second hour.
Indomethacin (10mg/kg) exhibited an anti-inﬂammatory
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Figure 3:Antinociceptiveeﬀectsofaqueous(EA)(a)andmethanol
(EM) (b) extracts of the bulbils of Dioscorea bulbifera L. var sativa
in pressure-caused pain. Each point represents the mean ± SEM of
6 animals; aP<. 05; bP<. 01, statistically signiﬁcant compared to
their respective control.
eﬀect with a maximum response of 62.36%(P<. 001) at the
fourth hour.
3.6. Histamine and Serotonin Induced Paw Oedema. Figure 5
shows the eﬀects of aqueous and methanol extracts on paw
oedema induced by histamine and serotonin. Both extracts
exhibited a signiﬁcant dose-dependent anti-inﬂammatory
activity with a maximum of 42.37% and 34.39% in
histamine-induced oedema and 42.04% and 46.92% in
serotonin-induced oedema, respectively for the aqueous and
methanol extracts at the dose of 600mg/kg. Pyrilamine
maleate signiﬁcantly (P<. 001) inhibited by 59.89% the
inﬂammation induced by histamine.
3.7. Formalin-Induced Paw Oedema. The aqueous and
methanol extract of the bulbils of Dioscorea bulbiferaEvidence-Based Complementary and Alternative Medicine 5
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Figure 4: Anti-inﬂammatory eﬀects of aqueous (EA) (a) and
methanol (EM) (b) extracts of the bulbils of Dioscorea bulbifera L.
var sativa on rat hind paw oedema induced by carrageenan. Each
point represents the mean ± SEM of 6 animals; aP<. 05; bP<
.01, cP<. 001 statistically signiﬁcant compared to their respective
control.
signiﬁcantly and dose dependently inhibited inﬂamma-
tion induced by formalin. At the dose of 600mg/kg,
they signiﬁcantly reduced the formation of paw oedema
by 45.02% for the aqueous extract and 32.06% for the
methanol extract, respectively at the 2nd and the 4th
hours. Diclofenac signiﬁcantly inhibited the acute inﬂam-
mation induced by formalin by 55.41% at the 4th hour
(Figure 6).
Both extracts showed a signiﬁcant inhibition of chronic
inﬂammation. The aqueous extract (300 and 600mg/kg)
signiﬁcantly inhibited the formaldehyde arthritis by 43.48%
and 50.43%, respectively on day 3. At the same doses,
methanol extract inhibited the chronic inﬂammation by
36.43% and 40.84%, respectively on days 4 and 5
(Figure 7).
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Figure 5: Eﬀects of aqueous and methanol extracts of the bulbils
of Dioscorea bulbifera L. var sativa on paw oedema induced by
histamine (a) and serotonin (b). Each bar represents the mean ±
SEM of 6 animals; cP<. 001 statistically signiﬁcant compared to
their respective control.
4. Discussion
Results from the present study showed that the aqueous and
methanol extracts from the bulbils of Dioscorea bulbifera var
Sativa have a potent antinociceptive eﬀect against chemical
painsprovokedbyaceticacidorformalinandaslightactivity
against mechanic pain induced by pressure. These extracts
also presented important anti-inﬂammatory eﬀects on acute
oedema induced by carrageenan, histamine, serotonin, or
formalin, and on chronic oedema induced by formalin.
The acetic acid-induced abdominal constriction method
is widely used for the evaluation of peripheral antinocicep-
tive activity [21] because it is very sensitive and able to
detect antinociceptive eﬀects of compounds at dose levels
that may appear inactive in other methods [22, 23]. Local6 Evidence-Based Complementary and Alternative Medicine
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Figure 6: Eﬀects of aqueous (EA) (a) and methanol (EM) (b)
extracts of the bulbils of Dioscorea bulbifera L. var sativa on acute
inﬂammation of paw oedema induced by formalin. Each point
represents the mean ± SEM of 6 animals; bP<. 01; cP<. 001
statistically signiﬁcant compared to their respective control.
peritoneal receptors are postulated to be partly involved in
the abdominal constriction response [24]. The method has
alsobeenassociatedwithprostanoidsingeneral,forexample,
increased levels of PGE2 and PGF2α in peritoneal ﬂuids [25]
as well as lipoxygenase products [26, 27]. The aqueous and
methanol extracts of D. bulbifera as indomethacin exhibited
markedinhibitoryeﬀectonthewrithingresponseinducedby
acetic acid. These results strongly suggest that these extracts
possess peripheral analgesic activity and their mechanisms
of action may be mediated through inhibition of local
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Figure 7: Eﬀects of aqueous (EA) (a) and methanol (EM) (b)
extracts of the bulbils of Dioscorea bulbifera L. var sativa on chronic
inﬂammation of paw oedema induced by formalin. Each point
represents the mean ± SEM of 6 animals; aP<. 05; bP<. 01,
cP<. 001 statistically signiﬁcant compared to negative control.
peritoneal receptors or arachidonic acid pathways, involv-
ing cyclo-oxygenases and/or lipoxygenases. The signiﬁcant
analgesic eﬀects observed on analgesy meter test buttress
the eﬀect of the extracts on peripheral local receptors even
though the extracts were less eﬀective on this model.
In the formalin test, there is a distinctive biphasic
nociceptive response termed early and late phases. Drugs
that act primarily on the central nervous system inhibit
both phases equally while peripherally acting drugs inhibit
the late phase [28, 29]. The early phase is probably a
direct result of stimulation of nociceptors in the paw and
reﬂects centrally mediated pain while the late phase is due
to inﬂammation with a release of serotonin, histamine,
bradykinin, and prostaglandins [30] and at least to some
degree, the sensitization of central nociceptive neurons [30–
32]. Suppression of both phases of pain was observed inEvidence-Based Complementary and Alternative Medicine 7
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Figure 8: Probable mechanism of the analgesic and anti-inﬂammatory activities of Dioscorea bulbifera extracts.
animals treated with aqueous and methanol extracts. These
results lend strong credence to the presence of both central
and peripheral eﬀects. Since D. bulbifera extracts were very
eﬃcient on visceral pain induced by acetic acid and on
the late phase of pain induced by formalin all mediated
by histamine, serotonin, bradykinin, and prostaglandins,
it is possible that these extracts possess anti-inﬂammatory
activities.
In order to verify this hypothesis, the aqueous and
the methanol extracts were assayed on acute and chronic
inﬂammation models. The paw oedema induced by car-
rageenan involves several chemical mediators such as his-
tamine, serotonin, bradykinin, and prostaglandins [33, 34].
Inthecarrageenin-inducedratpawoedemamodel,Dioscorea
bulbifera extracts showed signiﬁcant inhibitory eﬀect on
the oedema formation. This eﬀect started from the ﬁrst
hour and was maintained in all the inﬂammatory phases,
suggesting that the main mechanism of action of the tested
extracts may involve prostaglandin biosynthesis pathway
and may inﬂuence other mediators of inﬂammation. To
ascertain the eﬀect of the aqueous and methanol extracts on
the mediators’ activities, they were tested on inﬂammation
induced by histamine and serotonin. It was observed that
the plant extracts were capable of inhibiting oedema induced
by histamine and serotonin. Furthermore, oedema induced
by formalin was also signiﬁcantly inhibited by both extracts.
Acute inﬂammation induced by formalin results from cell
damage, which provokes the production of endogenous
mediators,suchas,histamine,serotonin,prostaglandins,and
bradykinin [35]. It can then be concluded from these results
that D. bulbifera extracts interfere with these inﬂammatory
mediators. But was it possible that these interesting acute
anti-inﬂammatory eﬀects extended to chronic inﬂamma-
tions which are the most invaliding factors?
To answer this question, both extracts were tested against
formalin-induced oedema which is a typical feature of an
established chronic inﬂammatory reaction and can serve
as a subchronic and chronic inﬂammatory test model for
investigation of antiarthritic and probable antiproliferative
substances [36]. The aqueous and methanol extracts showed
signiﬁcant inhibitory eﬀects on this model, suggesting that
the plant extracts possess subchronic anti-inﬂammatory
activities and may also serve as antiarthritic and antipro-
liferative medicine. Phytochemical screening revealed the
presenceofﬂavonoids,furanoids,andsaponinsinthebulbils
of Dioscorea bulbifera. Several ﬂavonoids with signiﬁcant
antinociceptive and/or anti-inﬂammatory eﬀects have been
isolated from medicinal plants [37–40]. Moreover, quercetin
and its derivatives that possess analgesic activities have been
isolated from the methanol extract of the bulbils of Dioscorea
bulbifera [5–8]. It is therefore, possible that both the
antinociceptive and anti-inﬂammatory eﬀects observed with
these extracts are attributed to its ﬂavonoid components.
In conclusion, this study has shown that the aqueous
and methanolic extracts of the bulbils of Dioscorea bulbifera
L. var sativa do possess signiﬁcant antinociceptive and
anti-inﬂammatory eﬀects that may be mediated through
inhibition of cell mediators such as histamine, serotonin,
bradykinin, and prostaglandins (Figure 8). These results
support the traditional use of this plant in some painful and
inﬂammatory conditions.
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